MedRhythms is redefining neurorehabilitation with the world’s first prescription music platform which combines sensors, software, and music to target neural circuitry and improve walking. InTandem® for chronic stroke and MOVIVE™ for Parkinson’s, deliver rhythmic auditory stimulation (RAS), a clinically validated intervention shown to enhance gait speed, quality, and functional independence. Both prescription-only devices are available nationwide and reimbursable by Medicare, commercial insurance, and the VA. Through a first-of-its-kind partnership with Universal Music Group and clinical studies with leading rehabilitation centers, MedRhythms is transforming access to evidence-based, in-home care for people with neurologic injury and disease. Find prescriber/safety information at intandemrx.com and movive.com.